Kauret al. show that in older patients, fibroblasts in the melanoma microenvironment produce the WNT–β-catenin inhibitor secreted frizzled-related protein 2 (SFRP2), which increases oxidative stress in melanoma cells, driving metastasis and therapeutic resistance.